- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Jul 11, 2023
B-05999565780128Holotype HLA 96/5 - Configuration A & CE v2 is an IVDD-legacy in vitro diagnostic registered in EUDAMED. It is classified as IVDD — Annex II List B. Manufactured by Omixon Biocomputing Ltd.. Placed on the EU market in Hungary. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
05999565780128H23HU-MF-000003018CE 694131(01)05999565780128
1 warning recorded — scroll inside the panel to see all entries.
Product Use Limitations For the best performance, please use the Holotype HLA 24/7 kit workflow and Omixon HLA Twin software for HLA typing by NGS with the materials, reagents, and equipment recommended in “Equipment, reagents, and supplies” section. Use of materials other than specified in section “Equipment, reagents, and supplies” section must be verified and validated by the user. Do not reconstitute or dilute the reagents in volumes other than described in this IFU. Do not use less volume of the reagents other than specified in this IFU. These activities can lead to performance errors. Omixon cannot provide support for any problems resulting from not following the protocol steps described in this IFU. Do not use the product in case of detectable damage to the components (broken vials, plate, loose caps etc.). Known Product Limitations Please refer to the Known Product Limitations (KPL)document for known ambiguities and known software limitation of the Holotype HLA product. The KPL is bundled with the IFU and also available on the Omixon website under MyHolotype > Support and Services > HLA Twin Instructions for Use, or you can request it from support@omixon.com.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Primary placement in Hungary; available across 4 countries total.
| Country | On market since | Until |
|---|---|---|
| HungaryPrimary placement | — | Still on market |
| Germany | — | Still on market |
| France | — | Still on market |
| Slovenia | — | Still on market |
European Medical Device Nomenclature — the EU product classification assigned to this device.
W01030499TISSUE TYPING REAGENTS - OTHERPrimary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
View in glossary →UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
View in glossary →IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →B-05999565780173On the marketHolotype HLA 96/11 - Configuration B & CE v2B-05999565780142On the marketHolotype HLA 96/11 - Configuration C & CE v2B-05999565780791On the marketHolotype HLA 96/5 - Configuration B & CE v2B-05999565780104On the marketHolotype HLA 96/5 - Configuration C & CE v2B-05999565780777On the marketHolotype HLA 96/7 - Configuration B & CE v2B-05999565780036On the marketNo certificate specifically references this device's Basic UDI-DI.
No certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.